Is this Educational Activity Right for Me?
The 2012 ASCCP Consensus Guidelines for Management of Women with Abnormal Cervical Cancer Screening Tests and CIN/AIS updates established broad concepts about secondary and tertiary prevention of cervical cancer. Generalizations, however, can be difficult to apply to specific clinical situations. This course provides clinicians with a working understanding of the rationale underlying the recommendations and offers an opportunity to use the updated guidelines to solve clinical problems resulting in improved patient outcomes.
The target audience is all intermediate level clinicians who interpret the results of cervical cancer screening tests and who diagnose, observe, and treat preinvasive disease (e.g., gynecologists, family physicians, advanced practice clinicians (to include NPs, CNMs, PA-Cs), gynecologic oncologists, and residents in obstetrics-gynecology and family medicine). Learners will have familiarity with the core natural history of human papillomaviruses and cervical intraepithelial neoplasia; the gross and colposcopic anatomy of the cervix, vagina, and vulva; and, the fundamental principles of management of lower genital tract diseases.
Course competencies and learning objectives:
This course has been designed to improve clinician competencies and practice and thus improve patient care. Upon completion of this activity, learners will be able to:
- Apply an understanding of the epidemiology and natural history of HPV and cervical cancer precursors to the rational screening of women for cervical cancer using the 2009 ACOG guidelines (medical knowledge);
- Apply the basic and clinical science underlying the 2012 ASCCP Consensus Guidelines to the individualized management of abnormal screening tests and preinvasive histologic lesions (systems-based practice, practice-based learning, patient care);
- Manage women from special populations (e.g., adolescent, postmenopausal, and pregnant women) with abnormal screening results and CIN/AIS (systems-based practice, practice-based learning, patient care);
- Implement cost-effective management of CIN, vulvar intraepithelial neoplasia (VIN) / vaginal intraepithelial neoplasia (VaIN), and HPV testing and vaccination (practice-based learning, patient care) and;
- Manage women treated for lower genital tract disease to identify recurrent or persistent lesions (practice-based learning, patient care).